Intrexon Corporation Company Profile (NYSE:XON)

About Intrexon Corporation (NYSE:XON)

Intrexon Corporation logoIntrexon Corporation (Intrexon) forms collaborations to create biologically-based products and processes using synthetic biology. The Company's domestic operations are in California, Florida, Maryland, and Virginia, and its primary international operations are in Belgium and Hungary. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components. The Company's synthetic biology capabilities include the ability to control the amount, location and modification of biological molecules to control the function and output of living cells and optimize for desired results at an industrial scale. The Company's technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; Cell Systems Informatics; RheoSwitch inducible gene switch; AttSite Recombinases; Protein Engineering; Laser-Enabled Analysis and Processing (LEAP), and ActoBiotics platform.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology & Medical Research - NEC
  • Sub-Industry: N/A
  • Symbol: NYSE:XON
  • CUSIP: N/A
  • Web: www.dna.com
Capitalization:
  • Market Cap: $2.84006 billion
  • Outstanding Shares: 119,606,000
Average Prices:
  • 50 Day Moving Avg: $23.46
  • 200 Day Moving Avg: $22.29
  • 52 Week Range: $18.41 - $32.90
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -49.19
  • P/E Growth: 0.56
Sales & Book Value:
  • Annual Revenue: $201.24 million
  • Price / Sales: 14.03
  • Book Value: $4.42 per share
  • Price / Book: 5.34
Profitability:
  • EBIDTA: ($89,610,000.00)
  • Net Margins: -76.32%
  • Return on Equity: -21.19%
  • Return on Assets: -12.80%
Debt:
  • Debt-to-Equity Ratio: 0.01%
  • Current Ratio: 3.11%
  • Quick Ratio: 2.90%
Misc:
  • Average Volume: 970,352 shs.
  • Beta: 1.51
  • Short Ratio: 20.7
 
Frequently Asked Questions for Intrexon Corporation (NYSE:XON)

What is Intrexon Corporation's stock symbol?

Intrexon Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "XON."

How were Intrexon Corporation's earnings last quarter?

Intrexon Corporation (NYSE:XON) announced its quarterly earnings results on Wednesday, May, 10th. The company reported ($0.26) earnings per share for the quarter, missing analysts' consensus estimates of ($0.22) by $0.04. The business had revenue of $53.70 million for the quarter, compared to analyst estimates of $49.08 million. Intrexon Corporation had a negative net margin of 76.32% and a negative return on equity of 21.19%. The company's quarterly revenue was up 23.7% on a year-over-year basis. During the same period last year, the firm earned ($0.55) earnings per share. View Intrexon Corporation's Earnings History.

Where is Intrexon Corporation's stock going? Where will Intrexon Corporation's stock price be in 2017?

6 brokers have issued 12-month price objectives for Intrexon Corporation's stock. Their forecasts range from $35.00 to $57.00. On average, they anticipate Intrexon Corporation's share price to reach $45.80 in the next twelve months. View Analyst Ratings for Intrexon Corporation.

Who are some of Intrexon Corporation's key competitors?

Who are Intrexon Corporation's key executives?

Intrexon Corporation's management team includes the folowing people:

  • Randal J. Kirk, Chairman of the Board, Chief Executive Officer
  • Thomas D. Reed Ph.D., Founder, Chief Science Officer
  • Rick L. Sterling CPA, Chief Financial Officer
  • Andrew J. Last Ph.D., Chief Operating Officer
  • Joel Liffmann, Senior Vice President - Finance
  • Jack Anthony Bobo, Senior Vice President, Chief Communications Officer
  • Ena Chan Cratsenburg, Senior Vice President - Consumer Sector
  • Nir Nimrodi, Senior Vice President - Corporate Development
  • Jeffrey T. Perez, Senior Vice President — Intellectual Property Affairs
  • Christopher Basta, Vice President - Investor Relations

Who owns Intrexon Corporation stock?

Intrexon Corporation's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Peregrine Capital Management LLC (0.39%), Sanders Morris Harris LLC (0.08%), Dixon Hubard Feinour & Brown Inc. VA (0.06%), CWM LLC (0.03%), Creative Planning (0.02%) and Addison Capital Co (0.02%). Company insiders that own Intrexon Corporation stock include Fred Hassan, Joel D Liffman, Nir Nimrodi, Randal J Kirk and Suma Krishnan. View Institutional Ownership Trends for Intrexon Corporation.

Who sold Intrexon Corporation stock? Who is selling Intrexon Corporation stock?

Intrexon Corporation's stock was sold by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, Dixon Hubard Feinour & Brown Inc. VA and Addison Capital Co. View Insider Buying and Selling for Intrexon Corporation.

Who bought Intrexon Corporation stock? Who is buying Intrexon Corporation stock?

Intrexon Corporation's stock was bought by a variety of institutional investors in the last quarter, including Cullinan Associates Inc., Creative Planning, Sanders Morris Harris LLC and CWM LLC. Company insiders that have bought Intrexon Corporation stock in the last two years include Fred Hassan, Joel D Liffman, Nir Nimrodi and Randal J Kirk. View Insider Buying and Selling for Intrexon Corporation.

How do I buy Intrexon Corporation stock?

Shares of Intrexon Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Intrexon Corporation's stock price today?

One share of Intrexon Corporation stock can currently be purchased for approximately $23.61.


MarketBeat Community Rating for Intrexon Corporation (NYSE XON)
Community Ranking:  3.1 out of 5 (  )
Outperform Votes:  159 (Vote Outperform)
Underperform Votes:  94 (Vote Underperform)
Total Votes:  253
MarketBeat's community ratings are surveys of what our community members think about Intrexon Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Intrexon Corporation (NYSE:XON) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $45.80 (93.99% upside)

Analysts' Ratings History for Intrexon Corporation (NYSE:XON)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
4/4/2017Stifel NicolausReiterated RatingBuy$57.00HighView Rating Details
3/14/2017WunderlichLower Price TargetBuy$50.00 -> $35.00HighView Rating Details
2/3/2017JMP SecuritiesSet Price TargetBuy$42.00N/AView Rating Details
12/29/2016Northland SecuritiesInitiated CoverageOutperform$40.00N/AView Rating Details
11/11/2016J P Morgan Chase & CoReiterated RatingHoldN/AView Rating Details
8/16/2016Griffin SecuritiesReiterated RatingBuy$55.00N/AView Rating Details
3/3/2016Bank of America CorporationReiterated RatingNeutral$41.00 -> $38.00N/AView Rating Details
3/1/2016MizuhoReiterated RatingNeutral$28.00 -> $29.00N/AView Rating Details
8/11/2015Merriman CapitalUpgradeNeutral -> Buy$85.00N/AView Rating Details
(Data available from 7/24/2015 forward)

Earnings

Earnings History for Intrexon Corporation (NYSE:XON)
Earnings by Quarter for Intrexon Corporation (NYSE:XON)
Earnings History by Quarter for Intrexon Corporation (NYSE XON)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/10/2017Q1 2017($0.22)($0.26)$49.08 million$53.70 millionViewN/AView Earnings Details
3/1/2017Q416($0.23)($0.37)$52.53 million$46.00 millionViewListenView Earnings Details
11/9/2016Q316($0.21)($0.24)$51.70 million$48.99 millionViewListenView Earnings Details
8/9/2016Q216($0.26)($0.42)$53.78 million$52.50 millionViewN/AView Earnings Details
5/10/2016Q1($0.20)($0.55)$46.26 million$43.40 millionViewListenView Earnings Details
2/29/2016Q415($0.18)($0.28)$41.82 million$41.50 millionViewListenView Earnings Details
11/9/2015Q3($0.21)($0.34)$40.84 million$53.40 millionViewN/AView Earnings Details
8/10/2015Q215($0.04)$0.01$55.93 million$44.90 millionViewListenView Earnings Details
5/11/2015Q115($0.12)$0.25$32.90 million$33.80 millionViewListenView Earnings Details
3/2/2015Q414($0.16)$0.18$26.11 million$31.10 millionViewN/AView Earnings Details
11/13/2014Q314($0.16)($0.53)$19.40 million$21.20 millionViewN/AView Earnings Details
8/14/2014Q214($0.13)($0.11)$9.39 million$11.80 millionViewN/AView Earnings Details
5/7/2014Q1$0.06$0.04$11.25 million$7.90 millionViewN/AView Earnings Details
3/31/2014Q413($0.14)($0.13)$8.38 million$7.10 millionViewN/AView Earnings Details
11/7/2013($0.03)$0.15$9.79 million$6.10 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Intrexon Corporation (NYSE:XON)
2017 EPS Consensus Estimate: ($0.79)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.22)($0.22)($0.22)
Q2 20171($0.19)($0.19)($0.19)
Q3 20171($0.20)($0.20)($0.20)
Q4 20171($0.18)($0.18)($0.18)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Intrexon Corporation (NYSE:XON)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Intrexon Corporation (NYSE:XON)
Insider Ownership Percentage: 56.30%
Institutional Ownership Percentage: 84.45%
Insider Trades by Quarter for Intrexon Corporation (NYSE:XON)
Institutional Ownership by Quarter for Intrexon Corporation (NYSE:XON)
Insider Trades by Quarter for Intrexon Corporation (NYSE:XON)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/13/2016Randal J KirkCEOBuy34,606$28.90$1,000,113.40View SEC Filing  
12/12/2016Joel D LiffmanSVPBuy8,500$28.62$243,270.00View SEC Filing  
12/1/2016Fred HassanDirectorBuy6,900$29.02$200,238.00View SEC Filing  
8/29/2016Nir NimrodiSVPBuy4,000$26.12$104,480.00View SEC Filing  
5/13/2016Randal J KirkCEOBuy41,830$23.92$1,000,573.60View SEC Filing  
12/11/2015Randal J KirkCEOBuy124,475$29.85$3,715,578.75View SEC Filing  
12/7/2015Randal J KirkCEOBuy237,525$30.69$7,289,642.25View SEC Filing  
12/4/2015Suma KrishnanSVPSell20,900$35.66$745,294.00View SEC Filing  
1/27/2015Randal J KirkCEOBuy555,556$27.00$15,000,012.00View SEC Filing  
5/13/2014Donald LehrInsiderBuy1,850$15.99$29,581.50View SEC Filing  
5/13/2014Randal KirkCEOBuy65,173$15.19$989,977.87View SEC Filing  
5/9/2014Kelly HuangSVPBuy3,200$15.78$50,496.00View SEC Filing  
5/9/2014Krish KrishnanCOOBuy20,900$14.21$296,989.00View SEC Filing  
3/27/2014Randal KirkCEOBuy243,001$25.72$6,249,985.72View SEC Filing  
3/4/2014Gregory Ian FrostSVPBuy100,000$25.95$2,595,000.00View SEC Filing  
8/13/2013Jeffrey B KindlerDirectorBuy33,000$16.00$528,000.00View SEC Filing  
8/13/2013Randal J KirkCEOBuy1,887,500$16.00$30,200,000.00View SEC Filing  
8/13/2013Thomas D ReedInsiderBuy1,800$16.00$28,800.00View SEC Filing  
8/13/2013Thomas R KasserSVPBuy5,000$16.00$80,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Intrexon Corporation (NYSE:XON)
Latest Headlines for Intrexon Corporation (NYSE:XON)
Source:
DateHeadline
americanbankingnews.com logoZacks: Analysts Expect Intrexon Corporation (NYSE:XON) Will Post Quarterly Sales of $56.97 Million
www.americanbankingnews.com - July 22 at 10:23 AM
finance.yahoo.com logoIntrexon Corp. breached its 50 day moving average in a Bearish Manner : XON-US : July 17, 2017
finance.yahoo.com - July 17 at 1:04 PM
nasdaq.com logoIntrexon Corp (XON) Shares Cross Above 200 DMA
www.nasdaq.com - July 14 at 1:31 AM
americanbankingnews.com logoIntrexon Corporation (XON) Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - July 13 at 1:05 PM
marketwatch.com logoOxitec Launching Friendly(TM) Aedes Project in Juiz de Fora, Brazil
www.marketwatch.com - July 12 at 9:35 AM
finance.yahoo.com logoOxitec Launching Friendly™ Aedes Project in Juiz de Fora, Brazil
finance.yahoo.com - July 12 at 9:35 AM
finance.yahoo.com logo3 Biggest Challenges Facing This Billionaire-Led Stock
finance.yahoo.com - July 12 at 9:35 AM
finance.yahoo.com logoETFs with exposure to Intrexon Corp. : July 10, 2017
finance.yahoo.com - July 11 at 9:49 AM
finance.yahoo.com logoOxitec's Friendly™ Aedes Mosquito Receives Positive Evaluation for European Standard in relation to Human Health and the Environment
finance.yahoo.com - July 6 at 3:27 PM
americanbankingnews.com logoIntrexon Corporation (XON) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - July 3 at 6:52 PM
prnewswire.com logoIntrexon Appoints Helen Sabzevari, Ph.D., Senior Vice President, Human Therapeutics and Head of Research and ... - PR Newswire (press release)
www.prnewswire.com - July 1 at 9:16 AM
finance.yahoo.com logoInvestors slowly start to push climate change up their agenda
finance.yahoo.com - June 29 at 4:25 PM
finance.yahoo.com logoIntrexon Appoints Helen Sabzevari, Ph.D., Senior Vice President, Human Therapeutics and Head of Research and Development of Precigen
finance.yahoo.com - June 29 at 4:25 PM
nasdaq.com logoZIOPHARM Oncology Announces Initiation of Stereotactic Treatment Cohort in Phase 1 Study of Ad-RTS-hIL-12 + Veledimex in Recurrent Glioblastoma
www.nasdaq.com - June 29 at 8:10 AM
americanbankingnews.com logoZacks: Brokerages Expect Intrexon Corporation (XON) Will Announce Quarterly Sales of $56.97 Million
www.americanbankingnews.com - June 28 at 12:06 PM
finance.yahoo.com logoETFs with exposure to Intrexon Corp. : June 26, 2017
finance.yahoo.com - June 26 at 8:45 PM
americanbankingnews.com logoIntrexon Corporation (XON) Expected to Post Earnings of -$0.21 Per Share
www.americanbankingnews.com - June 26 at 10:39 AM
nasdaq.com logoIntrexon (XON) Shares Cross Above 200 DMA
www.nasdaq.com - June 22 at 7:54 PM
americanbankingnews.com logoIntrexon Corporation (XON) Stock Rating Upgraded by BidaskClub
www.americanbankingnews.com - June 22 at 3:32 PM
finance.yahoo.com logoWhat Will Happen to Intrexon's Natural Gas-to-Chemicals Business?
finance.yahoo.com - June 22 at 2:51 PM
streetinsider.com logoForm 8-K INTREXON CORP For: Jun 16
www.streetinsider.com - June 17 at 7:49 AM
finance.yahoo.com logoETFs with exposure to Intrexon Corp. : June 16, 2017
finance.yahoo.com - June 17 at 7:48 AM
nasdaq.com logoWhy Is Intrexon (XON) Down 4.1% Since the Last Earnings Report? - Nasdaq
www.nasdaq.com - June 15 at 9:16 PM
finance.yahoo.com logoWhy Is Intrexon (XON) Down 4.1% Since the Last Earnings Report?
finance.yahoo.com - June 15 at 4:13 PM
finance.yahoo.com logoBP's Dudley seen reigning for years to restore major's might
finance.yahoo.com - June 15 at 4:13 PM
americanbankingnews.com logoIntrexon Corporation (XON) Lifted to "Sell" at BidaskClub
www.americanbankingnews.com - June 15 at 3:16 PM
finance.yahoo.com logoIntrexon Corp. :XON-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017
finance.yahoo.com - June 14 at 4:25 PM
News IconBRIEF-Intrexon, Johnson Matthey collaborate on production of peptide-based pharmaceutical ingredients
www.businessinsider.com - June 14 at 2:24 AM
prnewswire.com logoIntrexon and Johnson Matthey Collaborate on Fermentative Production of Peptide-based Active Pharmaceutical ... - PR Newswire (press release)
www.prnewswire.com - June 13 at 8:49 AM
finance.yahoo.com logoIntrexon and Johnson Matthey Collaborate on Fermentative Production of Peptide-based Active Pharmaceutical Ingredients
finance.yahoo.com - June 13 at 8:49 AM
finance.yahoo.com logoAquaBounty Acquires Fish Farming Facility in Indiana
finance.yahoo.com - June 13 at 8:49 AM
businesswire.com logoOragenics Presents Development of Novel Lantibiotic Against Clostridium difficile at the ICAAC Conference - Business Wire (press release)
www.businesswire.com - June 7 at 1:19 AM
americanbankingnews.com logoIntrexon Corp (XON) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - June 6 at 6:40 PM
finance.yahoo.com logoZIOPHARM Oncology Announces Positive Updated Results of Ad-RTS-hIL-12 + Veledimex in Recurrent Glioblastoma at the 2017 ASCO Annual Meeting
finance.yahoo.com - June 6 at 2:56 AM
americanbankingnews.com logoZacks: Brokerages Anticipate Intrexon Corp (XON) Will Announce Quarterly Sales of $56.97 Million
www.americanbankingnews.com - June 2 at 3:20 PM
finance.yahoo.com logoZIOPHARM to Present at the Jefferies 2017 Global Healthcare Conference
finance.yahoo.com - June 2 at 7:38 AM
finance.yahoo.com logoIntrexon's Head of Environment Sector Joins Brazil Investment Forum to Discuss Importance of Vector Control and Economic Impact of Vector-borne Diseases
finance.yahoo.com - May 31 at 9:06 AM
americanbankingnews.com logo Analysts Expect Intrexon Corp (XON) Will Announce Earnings of -$0.21 Per Share
www.americanbankingnews.com - May 31 at 7:48 AM
seekingalpha.com logoIntrexon (XON) Presents At B. Riley & Co. Institutional Investor Conference - Slideshow
seekingalpha.com - May 26 at 9:04 AM
prnewswire.com logoIntrexon to Present at Upcoming Investor and Industry Conferences - PR Newswire (press release)
www.prnewswire.com - May 25 at 8:05 AM
finance.yahoo.com logoIntrexon to Present at Upcoming Investor and Industry Conferences
finance.yahoo.com - May 24 at 8:04 AM
seekingalpha.com logoIntrexon (XON) Presents At Bank of America Merrill Lynch 2017 Health Care Conference - Slideshow
seekingalpha.com - May 22 at 7:46 PM
finance.yahoo.com logoWhat You Missed in Intrexon's Quarterly Report
finance.yahoo.com - May 19 at 1:53 PM
finance.yahoo.com logoIntrexon Appoints Dr. Mark Carnegie-Brown as CEO of Oxitec
finance.yahoo.com - May 19 at 1:53 PM
finance.yahoo.com logoZIOPHARM Oncology Announces Results of Ad-RTS-hIL-12 + Veledimex in Recurrent Glioblastoma to be Presented at the 2017 ASCO Annual Meeting
finance.yahoo.com - May 17 at 11:22 PM
finance.yahoo.com logoFibrocell to Present at Inaugural Cell & Gene Exchange 2017
finance.yahoo.com - May 17 at 8:08 AM
prnewswire.com logoIntrexon to Present at the Bank of America Merrill Lynch 2017 ... - PR Newswire (press release)
www.prnewswire.com - May 16 at 8:05 AM
nasdaq.com logoIntrexon Breaks Above 200-Day Moving Average - Bullish for XON
www.nasdaq.com - May 15 at 7:52 PM
americanbankingnews.com logoIntrexon Corp (XON) Forecasted to Post FY2019 Earnings of $0.31 Per Share
www.americanbankingnews.com - May 15 at 10:02 AM
finance.yahoo.com logoIntrexon to Present at the Bank of America Merrill Lynch 2017 Healthcare Conference
finance.yahoo.com - May 15 at 8:20 AM

Social

Chart

Intrexon Corporation (XON) Chart for Monday, July, 24, 2017

This page was last updated on 7/24/2017 by MarketBeat.com Staff